1393 results
MoH Pakistan
AMÉLIORATION DE LA COUVERTURE VACCINALE CONTRE LA COVID-19 PARMI LES POPULATIONS RÉFUGIÉES AU PAKISTAN
Leonard W. Heyerdah, Bagrey Ngwira, Rachel Demolis, Gabriel Nyirenda, Maurice Mwesawina, Florentina Rafael , Philippe Cavailler, Jean Bernard Le Gargasson, Martin A. Mengel, Bradford D. Gessner, Elise Guillermet
A reactive campaign using two doses of Shanchol Oral Cholera Vaccine (OCV) was implemented in 2016 in the Lake Chilwa Region (Malawi) targeting fish dependent communities. Three strategies for the...
Helen S. Marshall, Peter C. Richmond, Johannes Beeslaar, Qin Jiang , Kathrin U. Jansen, Maria Garcés-Sánchez, Federico Martinón-Torres, Leszek Szenborn, Jacek Wysocki,, Joseph Eiden, Shannon L. Harris, Thomas R. Jones, Su-San Lee, John L. Perez
Background Bivalent rLP2086 is a recombinant factor H binding protein-based vaccine approved in the USA for prevention of meningococcal serogroup B disease in 10–25-year-olds. We aimed to assess...
Helen E. D. Burchett, Sandra Mounier-Jack, Sergio Torres-Rueda, Ulla K. Griffiths, Pierre Ongolo-Zogo, Stephen Rulisa, Jean-Marie Edengue, Enrique Chavez, Yayehirad Kitaw, Mitike Molla, Mamadou Konate, Lawrence Gelmon, Washington Onyango-Ouma, Mylene Lagarde, Anne Mills
The study found that new vaccines were viewed positively and seemed to integrate well into existing health systems. The introductions were found to have had no impact on many elements within the...
Heidi Larson, Julie Leask, Sian Aggett, Nick Sevdalis, Angus Thomson
There is increasingly broad global recognition of the need to better understand determinants of vaccine acceptance. Fifteen social science, communication, health, and medical professionals (the...
Heidi J.Larson, Caitlin Jarrett, William S. Schulz, Mohuya Chaudhuri, Yuqing Zhou, Ève Dubé, Melanie Schuster, Noni E. MacDonald, Rose Wilson
In March 2012, the SAGE Working Group on Vaccine Hesitancy was convened to define the term “vaccine hesitancy”, as well as to map the determinants of vaccine hesitancy and develop tools to...
Heidi J. Larson, David M. D. Smith, Pauline Paterson, Melissa Cumming, Elisabeth Eckersberger, Clark C. Freifeld, Isaac Ghinai, Caitlin Jarrett, Louisa Paushter, John S. Brownstein, Lawrence C. Madoff
The intensity, spread, and effects of public opinion about vaccines are growing as new modes of communication speed up information sharing, contributing to vaccine hesitancy, refusals, and disease...
Heather MacDougall, Laurence Monnais
Experts have pointed to apathy as a key factor in the ongoing battle to eliminate measles transmission through universal vaccination. Apathy has taken many forms in Canada since the 1960s and could...
C. Mary Healy, Diana P. Montesinos, Amy B Middleman
Most surveyed parents believe vaccines are important for child health and rate disease prevention higher than number of injections entailed. Providers underestimate the importance of some vaccines to...
Hazzie Mvula, Ellen Heinsbroek , Menard Chihana, Amelia C. Crampin, Storn Kabuluzi, Geoffrey Chirwa, Charles Mwansambo, Anthony Costello, Nigel A. Cunliffe, Robert S. Heyderman, , Neil French, Naor Bar-Zeev
Background Malawi introduced pneumococcal conjugate vaccine (PCV13) and monovalent rotavirus vaccine (RV1) in 2011 and 2012 respectively, and is planning the introduction of a second-dose measles...
Hayley A. Hutchings, Annette Evans, Peter Barnes, Melanie A. Healy, Michelle James-Ellison, Ronan A. Lyons, Alison Maddocks, Shantini Paranjothy, Sarah E. Rodgers, Frank Dunstan
There are conflicting findings regarding the impact of residential mobility on immunisation status. Our aim was to determine whether there was any association between residential mobility and take up...
Harriet Batista Ferrer, Caroline Trotter, Matthew Hickman, Suzanne Audrey
Background Vaccination against Human Papillomavirus (HPV) is recommended for adolescent young women prior to sexual debut to reduce cervical cancer related mortality and morbidity. Understanding...
Hannah Christensen, Caroline L. Trotter, Matthew Hickman, W. John Edmunds
The study concludes that in the short term, case reduction is greatest with routine infant immunisation (26.3% of cases averted in the first five years). This strategy could be cost effective at £3...
Hanani Tabana, Lilian D. Dudley, Stephen Knight, Neil Cameron, Hassan Mahomed, Charlyn Goliath, Rudolf Eggers, Charles S. Wiysonge
Background The Expanded Programme on Immunisation (EPI) has increased the number of antigens and injections administered at one visit. There are concerns that more injections at a single...
Halima Boubacar Maïnassara, Juliette Paireau, Issa Idi, Jean-Paul Moulia Pelat, Odile Ouwe Missi Oukem-Boyer, Arnaud Fontanet, Judith E. Mueller
To inform epidemic response strategies for the African meningitis belt after a meningococcal serogroup A conjugate vaccine was introduced in 2010, the researchers compared the effectiveness and...
Inaya Hajj Hussein, Nour Chams, Sana Chams, Skye El Sayegh, Reina Badran, Mohamad Raad, Alice Gerges-Geagea, Angelo Leone, Abdo Jurjus
Multiple cornerstones have shaped the history of vaccines, which may contain live-attenuated viruses, inactivated organisms/viruses, inactivated toxins, or merely segments of the pathogen that could...
Hafsa Imran, Dania Raja, Nicholas C. Grassly, M. Zubair Wadood, Rana M. Safdar, Kathleen M. O’Reilly
Background: Within Pakistan, estimates of vaccination coverage with the pentavalent vaccine, oral polio vaccine (OPV) and measles vaccine (MV) in 2011 were reported to be 74%, 75% and 53%,...
Muhammad Atif Habib, Sajid Soofi, Ondrej Mach, Didar Alam, Zaid Bhatti, William C. Weldon, Steven M. Oberste, Roland Sutter, Zulfiqar A. Bhutta, Tariq Samejo
BACKGROUND: Considering the current polio situation Pakistan needs vaccine combinations to reach maximum population level immunity. The trial assessed whether inactivated poliovirus vaccine (IPV)...
H. Huang, T. ZHU, C. GAO, Z. GAO, Y. LIU , , Y. DING, J. SUN, L. GUO, P. LIU, D. CHEN, L. WANG, S. WU, Y. ZHANG
Active symptom surveillance was applied to three selected communities ( 160 147 persons) in Tianjin from 2010 to 2012. The researchers examined 1089 individuals showing pertussis-like symptoms, of...
H. Chaouch, H. Chaouch, W. HACHFI, I. FODHA, O. KALLALA, S. SAADI, A. BOUSAADIA, F. LAZRAG, I. BOUGMIZA, M. AOUNI, A. TRABELSI, E. BEN JAZIA, A. LETAIEF
Hepatitis B virus (HBV) vaccination has been part of the Expanded Programme of Immunization (EPI) in Tunisia since 1995. The aim of this study was to evaluate, for the first time, the impact of mass...
Xiaoyan Guo, Kimberley A. Simmonds, Jill Svenson, Shannon E. MacDonald
BACKGROUND: Children under the age of 12 months may receive an early dose of measles-mumps-rubella (MMR) vaccine to provide short-term protection in the case of a disease outbreak. Following a...
Gunjan Taneja et al.
Newborn Vaccination is identified as a critical parameter for evaluating the overall performance of immunization programs with guidelines clearly advocating for administration of BCG, OPV zero dose...
Nicole Guiso, Johannes Liese, Stanley Plotkin
Despite the widespread availability of 2 classes of effective vaccines, whole cell and acellular, Bordetella pertussis infection remains a global epidemic. Pertussis is primarily a disease of...
Rudzani Muloiwa, Nicole Wolter, Tina Tan, A.J. Chitkara, Kevin D. Forsyth, Carl-Heinz Wirsing von König, Gregory Hussey
Pertussis remains a major cause of morbidity and mortality, particularly in infants and young children, and despite the availability of vaccines and pertinent national and international guidelines....
Ulla Kou Griffiths, Fiammetta Maria Bozzani , Collins Chansa, Anthony Kinghorn, Penelope Kalesha-Masumbu, Cheryl Rudd, Roma Chilengi, Logan Brenzel, Carl Schütte
BACKGROUND: Introduction of new vaccines in low- and lower middle-income countries has accelerated since Gavi, the Vaccine Alliance was established in 2000. This study sought to (i) estimate the...
Greice Madeleine Ikeda do Carmo, Catherine Yen, Jennifer Cortes, Alessandra Araújo Siqueira, Wanderson Kleber de Oliveira, Catherine Yen, Jennifer Cortes, Alessandra Araújo Siqueira, Wanderson Kleber de Oliveira, Juan José Cortez-Escalante, Ben Lopman, Brendan Flannery, Lucia Helena de Oliveira, Eduardo Hage Carmo, Manish Patel
After the introduction of rotavirus vaccination for infants, significant declines for three full years were observed in under-5-y diarrhea-related mortality and hospital admissions for diarrhea in...
Greice Madeleine Ikeda do Carmo, Catherine Yen, Jennifer Cortes, Alessandra Araújo Siqueira, Wanderson Kleber de Oliveira, Juan José Cortez-Escalante, Ben Lopman, Brendan Flannery, Lucia Helena de Oliveira, Eduardo Hage Carmo, Manish Patel
In 2006, Brazil began routine immunization of infants <15 wk of age with a single-strain rotavirus vaccine. The researchers evaluated whether the rotavirus vaccination program was associated with...
Grant A. Mackenzie, David Ameh, Malick Ndiaye, Oyedeji Adeyemi, Jayani Pathirana, Yekini Olatunji, Bade Abatan, Bilquees S. Muhammad, Augustin E. Fombah, Debasish Saha, Ian Plumb, Aliu Akano, Bernard Ebruke, Readon C. Ideh, Bankole Kuti, Peter Githua, Emmanuel Olutunde, Ogochukwu Ofordile, Edward Green, Effua Usuf, Henry Badji, Usman N. A. Ikumapayi, Ahmad Manjang, Rasheed Salaudeen, E. David Nsekpong, Sheikh Jarju, Martin Antonio, Sana Sambou, Lamin Ceesay, Yamundow Lowe-Jallow, Momodou Jasseh, Kim Mulholland, Maria Knoll, Orin S. Levine, Stephen R. Howie, Richard A. Adegbola, Brian M. Greenwood, Tumani Corrah, Philip C. Hill, David J. Jeffries, Ilias Hossain, Uchendu Uchendu
The Gambian PCV programme reduced the incidence of invasive pneumococcal disease in children aged 2–59 months by around 55%. Further surveillance is needed to ascertain the maximum effect of the...
Grace M. Lee, Ken Kleinman, Stephen Pelton , Marc Lipsitch, Susan S. Huang, Matt Lakoma, Maya Dutta-Linn, Melisa Rett, William P. Hanage, Jonathan A. Finkelstein
BACKGROUND: Rates of invasive pneumococcal disease have declined since widespread introduction of pneumococcal conjugate vaccines (PCVs) in the United States. We evaluated the impact of immunization...
Esther González-Escartín, Itziar Angulo López, Elsa Ots Ruiz, Luis Martínez-Martínez , María J. Cabero Pérez
OBJECTIVE: To analyze the characteristics of pneumococcal meningitis in children ≤ 14 years old following the market introduction of pneumococcal conjugate vaccines in our community. METHODS:...
Sarah L. Goff, Kathleen M. Mazor, Shawn J. Gagne, Kristin C. Corey, Diane R. Blake
The study concludes that targeting age groups with lower vaccination rates may increase overall vaccine uptake. Additional quantitative analyses of patient–physician discussions about vaccine may...
Glynis Dunn, Dimitra Klapsa, Thomas Wilton, Lindsay Stone, Philip D. Minor, Javier Martin
There are currently huge efforts by the World Health Organization and partners to complete global polio eradication. With the significant decline in poliomyelitis cases due to wild poliovirus in...
Glen R. Abedi, Jeffry D. Mutuc, Jacqueline Lawler, Zanie C. Leroy, Jean M. Hudson, Debra S. Blog, Cynthia R. Schulte, Elizabeth Rausch-Phung, Ikechukwu U. Ogbuanu, Kathleen Gallagher, Preeta K. Kutty
During a 2009–2010 mumps outbreak in a New York State village, a third dose of measles, mumps, and rubella (MMR) vaccine was administered to children in three schools as a control measure....
Gloria J. Kang, Sinclair R. Ewing-Nelson, Lauren Mackey, James T. Schlitt, Achla Marathe, Kaja M. Abbas, Samarth Swarup
Background: Vaccine hesitancy continues to contribute to suboptimal vaccination coverage in the United States, posing significant risk of disease outbreaks, yet remains poorly understood. Methods: We...
R. A. Gladstone, J. M. Jefferies, S. N. Faust, S. C. Clark
Streptococcus pneumoniae is an important pathogen worldwide. Accurate sampling of S. pneumoniae carriage is central to surveillance studies before and following conjugate vaccination programmes to...
Giuseppe Traversa, Stefania Spila-Alegiani, Clara Bianchi, Marta Ciofi degli Atti, Luisa Frova, , Marco Massari, Roberto Raschetti, Stefania Salmaso, Gianpaolo Scalia Tomba
The signal of an association between vaccination in the second year of life with a hexavalent vaccine and sudden unexpected deaths (SUD) in the two days following vaccination was reported in Germany...
Maria Giufrè, Rita Cardines, Maria Grazia Caporali, Marisa Accogli, Fortunato D'Ancona, Marina Cerquetti
The introduction of Haemophilus influenzae type b (Hib) conjugate vaccines has greatly reduced the incidence of invasive Hib disease. However, concern exists about the possible emergence of \"strain...
Gillian K. SteelFisher, Robert J. Blendon, Sherine Guirguis, William Lodge II, Hannah Caporello, Vincent Petit, Michael Coleman, Matthew R. Williams, Sardar Mohammad Parwiz, Melissa Corkum, Scott Gardner, Eran N. Ben-Porath
Background: Eradication of poliovirus from endemic countries relies on vaccination of children with oral polio vaccine (OPV) many times a year until the age of 5 years. We aimed to determine...
Gili Regev-Yochay, Izzeldin Abullaish, Richard Malley, Bracha Shainberg, Miriam Varon, Yulia Roytman, Arnona Ziv, Aviva Goral, Abedallah Elhamdany, Galia Rahav, Meir Raz
Pneumococcal infections cause major morbidity and mortality in developing countries. The researchers report the epidemiology of S. pneumoniae carriage in a developing region, the Gaza strip, and...
Courtney Gidengil, Tracy A. Lieu, Katherine Payne, Donna Rusinak, Mark Messonnier, Lisa A. Prosser
New combination vaccines reduce the number of injections needed for immunization. However, possible drawbacks include higher prices, extra doses of vaccine antigens and increased minor adverse...
Dustin G. Gibson, Benard Ochieng, E. Wangeci Kagucia, Joyce Were, Kyla Hayford, Lawrence H. Moulton, Orin S. Levine, Frank Odhiambo, Katherine L. O'Brien, Daniel R. Feikin
BACKGROUND: As mobile phone access continues to expand globally, opportunities exist to leverage these technologies to support demand for immunisation services and improve vaccine coverage. We aimed...
Gianluca Russo, Alessandro Miglietta, Patrizio Pezzotti, Rodrigue Mabvouna Biguioh, Georges Bouting Mayaka, Martin Sanou Sobze, Paola Stefanelli, Vincenzo Vullo , Giovanni Rezza
Inadequate immunization coverage with increased risk of vaccine preventable diseases outbreaks remains a problem in Africa. Moreover, different factors contribute to incomplete vaccination status....
Cristina Giambi, Massimo Fabiani, Fortunato D'Ancona, Lorenza Ferrara, Daniel Fiacchini, Tolinda Gallo, Domenico Martinelli, Maria Grazia Pascucci, Rosa Prato, Antonietta Filia, Antonino Bella , Martina Del Manso, Caterina Rizzo, Maria Cristina Rota
In Italy, in 2016, we conducted a cross-sectional survey to estimate vaccine hesitancy and investigate its determinants among parents of children aged 16-36 months. Data on parental attitudes and...
Germaine Hanquet, Marta Valenciano, François Simondon, Alain Moren
Once a vaccine is licensed and introduced in the population, post-licensure studies are required to measure vaccine effectiveness and impact of vaccination programmes on the population at large....
George Armah, Kristen D. C. Lewis, Margaret M. Cortese, Umesh D. Parashar, Akosua Ansah, Lauren Gazley, John C. Victor, Monica M. McNeal, Fred Binka, A. Duncan Steele
Background. The recommended schedule for receipt of 2-dose human rotavirus vaccine (HRV) coincides with receipt of the first and second doses of diphtheria, pertussis, and tetanus vaccine (ie, 6...
Gebre Asmamaw Lakew, Eshetu Wassie, Ayesheshem Ademe, Ayalneh Fenta, Solomon Wube, Mihret Werede, Achenef Kidane, Leulseged Mekonnen, Teklehaimanot Gebre Hiwot, Kathleen Gallagher
Introduction: trend analyses of non-polio AFP and stool adequacy rates in Amhara Region showed optimal performance over the years. However, sub regional gaps continue to persist in certain zones...
Gayatri Amirthalingam, Nick Andrews, Helen Campbell, Sonia Ribeiro, Edna Kara, Katherine Donegan, Norman K. Fry, Elizabeth Miller, Mary Ramsay
In October, 2012, a pertussis vaccination programme for pregnant women was introduced in response to an outbreak across England. The researchers aimed to assess the vaccine effectiveness and the...
Gabriela García Gabarrot, Mariana López Vega, Gabriel Pérez Giffoni, Silvia Hernández, Pablo Cardinal, Viviana Félix, Jean Marc Gabastou, Teresa Camou
In 2008, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into the routine childhood immunization program in Uruguay, with a 2+1 schedule. In 2010, PCV13 replaced PCV7, and the same...